Run-in-phase results from a multicenter phase II trial to evaluate pembrolizumab (P) and gemcitabine (Gem) in patients (pts) with HER2-negative advanced breast cancer (ABC): GEICAM/2015-04 PANGEA-Breast
Titel:
Run-in-phase results from a multicenter phase II trial to evaluate pembrolizumab (P) and gemcitabine (Gem) in patients (pts) with HER2-negative advanced breast cancer (ABC): GEICAM/2015-04 PANGEA-Breast
Auteur:
Quiroga, V. Holgado, E. Alonso, J.L. Andres, R. Moreno Anton, F. Alamo De La Gala, M.D.C. Henao, F. Cirauqui Cirauqui, B. Margeli, M. Cortes Castan, J. Gion Cortes, M. Soto, A. Benito, S. Escudero, M.J. Chiesa, M. Caballero, R. Bezares Montes, S. Carrasco, E.M. De La Cruz Merino, L.